NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 201 filers reported holding NOVOCURE LTD in Q1 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $434,796 | -65.2% | 10,477 | -49.6% | 0.00% | -50.0% |
Q1 2023 | $1,249,649 | -1.5% | 20,779 | +20.2% | 0.00% | 0.0% |
Q4 2022 | $1,268,295 | -17.8% | 17,291 | -14.9% | 0.00% | -33.3% |
Q3 2022 | $1,543,000 | -65.2% | 20,314 | -68.1% | 0.00% | -25.0% |
Q2 2022 | $4,429,000 | -26.4% | 63,729 | -12.3% | 0.00% | 0.0% |
Q1 2022 | $6,019,000 | -46.2% | 72,641 | -51.2% | 0.00% | -50.0% |
Q4 2021 | $11,192,000 | -10.2% | 148,980 | +38.9% | 0.01% | -20.0% |
Q3 2021 | $12,462,000 | -70.7% | 107,273 | -44.0% | 0.01% | -72.2% |
Q2 2021 | $42,508,000 | +200.1% | 191,632 | +78.8% | 0.04% | +157.1% |
Q1 2021 | $14,165,000 | -8.3% | 107,166 | +20.1% | 0.01% | -6.7% |
Q4 2020 | $15,441,000 | -31.3% | 89,235 | -55.8% | 0.02% | -42.3% |
Q3 2020 | $22,464,000 | +51.8% | 201,812 | -19.1% | 0.03% | +52.9% |
Q2 2020 | $14,801,000 | +50.2% | 249,592 | +70.6% | 0.02% | +30.8% |
Q1 2020 | $9,854,000 | -20.2% | 146,329 | -0.1% | 0.01% | +18.2% |
Q4 2019 | $12,346,000 | -9.5% | 146,498 | -19.9% | 0.01% | -15.4% |
Q3 2019 | $13,646,000 | -8.4% | 182,987 | -22.4% | 0.01% | -7.1% |
Q2 2019 | $14,901,000 | -11.4% | 235,672 | -32.5% | 0.01% | -17.6% |
Q1 2019 | $16,814,000 | +13.6% | 349,067 | -21.2% | 0.02% | +6.2% |
Q4 2018 | $14,803,000 | -51.3% | 442,887 | -23.7% | 0.02% | -42.9% |
Q3 2018 | $30,410,000 | +39.0% | 580,337 | -16.9% | 0.03% | +33.3% |
Q2 2018 | $21,870,000 | +8.1% | 698,723 | -24.7% | 0.02% | +10.5% |
Q1 2018 | $20,231,000 | +88.0% | 928,025 | +74.2% | 0.02% | +111.1% |
Q4 2017 | $10,760,000 | – | 532,709 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |